Genetron, CStone start clinical trial in China to develop CDx for avapritinib

Avapritinib is a kinase inhibitor discovered by CStone’s partner Blueprint Medicines.(Credit: Belova59 from Pixabay.)



Related Article
Recommended Whitepaper

View More